DS107E

DRUG2 trials

Sponsors

DS Biopharma

Conditions

Atopic Dermatitis

Phase 2

Efficacy and Steroid Sparing Potential Study of DGLA Cream in Patients With Moderate to Severe Atopic Dermatitis

CompletedNCT03676036

DS BiopharmaAtopic Dermatitis

Start: 2015-06-30End: 2018-07-31Updated: 2018-09-18

Efficacy and Steroid Sparing Potential Study of DGLA Cream in Early Childhood Patients With Moderate to Severe Atopic Dermatitis

CompletedNCT03676933

DS BiopharmaAtopic Dermatitis

Start: 2015-10-31End: 2016-04-25Updated: 2019-02-08